New biopsy method aims to cut unnecessary prostate cancer diagnoses

NCT ID NCT07296042

First seen Jan 05, 2026 · Last updated May 31, 2026 · Updated 18 times

Summary

This study compares two ways of taking prostate biopsies in men with suspected prostate cancer. The new method takes samples from the MRI-visible spot and nearby areas, while the standard method also samples random spots across the prostate. The goal is to see if the new approach catches dangerous cancers just as well but finds fewer harmless ones, reducing overdiagnosis and anxiety. About 456 men will take part across multiple centers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHI Mont de Marsan - Site de Layné

    Mont-de-Marsan, 40024, France

    Contact Phone: •••-•••-••••

  • CHU de Bordeaux

    Bordeaux, 33000, France

    Contact Phone: •••-•••-••••

  • Clinique La Croix du Sud - RAMSAY Santé

    Quint-Fonsegrives, 31130, France

    Contact Phone: •••-•••-••••

  • Hôpital Nord, Assistance Publique des Hôpitaux de Marseille

    Marseille, 13015, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital privé des Peupliers - Ramsay Santé

    Paris, 75013, France

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.